Kim et al., 2017 - Google Patents
The involvement of ginseng berry extract in blood flow via regulation of blood coagulation in rats fed a high-fat dietKim et al., 2017
View HTML- Document ID
- 11696038373777495361
- Author
- Kim M
- Lee J
- Jung S
- Kim J
- Shin J
- Lee H
- Publication year
- Publication venue
- Journal of ginseng research
External Links
Snippet
Background The present study investigated the effect of ginseng berry hot water extract (GBx) on blood flow via the regulation of lipid metabolites and blood coagulation in rats fed a high-fat diet (HFD). Methods Sixty rats were divided into five groups in descending order of …
- 235000009200 high fat diet 0 title abstract description 91
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | The involvement of ginseng berry extract in blood flow via regulation of blood coagulation in rats fed a high-fat diet | |
Cui et al. | A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke | |
Ling et al. | Hypolipidemic effect of pure total flavonoids from peel of Citrus (PTFC) on hamsters of hyperlipidemia and its potential mechanism | |
Zhao et al. | Hypolipidaemic effects and mechanisms of the main component of Opuntia dillenii Haw. polysaccharides in high-fat emulsion-induced hyperlipidaemic rats | |
Liu et al. | Taoren–Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation | |
Liu et al. | Focus on notoginsenoside R1 in metabolism and prevention against human diseases | |
Rasekh et al. | Acute and subchronic oral toxicity of Galega officinalis in rats | |
Yan et al. | Protective effects of resveratrol improve cardiovascular function in rats with diabetes | |
Fan et al. | Effects of Danhong injection on platelet aggregation in hyperlipidemia rats | |
Yin et al. | Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats | |
Chen et al. | Kaempferol and atherosclerosis: From mechanism to medicine | |
Liang et al. | Ginsenosides improve nonalcoholic fatty liver disease via integrated regulation of gut microbiota, inflammation and energy homeostasis | |
Yuan et al. | Hypoglycemic and anti-inflammatory effects of seabuckthorn seed protein in diabetic ICR mice | |
Tahraoui et al. | Acute and sub-chronic toxicity of a lyophilised aqueous extract of Centaurium erythraea in rodents | |
Saba et al. | Black ginseng extract ameliorates hypercholesterolemia in rats | |
Mekhfi et al. | Antithrombotic activity of argan oil: An in vivo experimental study | |
Azevedo et al. | Anti-thrombotic effect of chronic oral treatment with Orbignya phalerata Mart. | |
Li et al. | Effect of the polyphenol‐rich extract from Allium cepa on hyperlipidemic sprague‐dawley rats | |
Fu et al. | Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis | |
Kim et al. | Antithrombotic activity of methanolic extract of Umbilicaria esculenta | |
He et al. | Evaluation antithrombotic activity and action mechanism of myricitrin | |
Yun et al. | Effects of Korean red ginseng and its mixed prescription on the high molecular weight dextran-induced blood stasis in rats and human platelet aggregation | |
Wang et al. | Regulation of SIRT3/FOXO1 signaling pathway in rats with non-alcoholic steatohepatitis by salvianolic acid B | |
Ma et al. | Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip | |
Tzeng et al. | Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver |